Your search for comorbidities returned 15 results

Researchers sought to determine whether screening vs no screening for atrial fibrillation could reduce morbidity and mortality.

Using data on patients with existing atrial fibrillation (AF), researchers analyzed the link between diabetes with the AF phenotype and cardiac and neurologic comorbidities.

Using an IV sotalol formulation, researchers were able to develop a safe and cost-effective option for administering the antiarrhythmic drug.

Researchers sought to determine whether the stress of a contentious political election increases the risk of arrhythmia in patients with known susceptibility.

Sodium-glucose cotransporter 2 inhibitors use may reduce cardiac arrhythmia risk, including the risk for atrial fibrillation.

In patients hospitalized for COPD exacerbation, the presence of atrial fibrillation may increase the risk of in-hospital mortality.

Patients with atrial fibrillation who use anticoagulants and have a history of gastrointestinal bleeding may be at higher risk for subsequent major gastrointestinal bleeding.

The incidence of patients who are not responsive to cardiac resynchronization therapy was found to be high.

Advanced interatrial block is a favorable parameter to estimate the presence of low voltage area and it may provide useful information for the treatment strategy for atrial fibrillation and the prediction of the outcome after ablation.

Patients with monitoring device like pacemaker had a significantly increased risk of being diagnosed with AF in comparison to general population with no difference in incidence of AF when 2 different monitoring devices were compared.